An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses
Autor: | Samira Muñoz-Cruz, Ezequiel M. Fuentes-Pananá, Angélica Aponte-López, Jennifer Enciso |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Databases Factual anti-tumor functions Stimulation mast cells Breast Neoplasms Disease Biology Models Biological Catalysis Article Disease-Free Survival Inorganic Chemistry lcsh:Chemistry 03 medical and health sciences 0302 clinical medicine Breast cancer breast cancer medicine Humans Physical and Theoretical Chemistry Molecular Biology Gene lcsh:QH301-705.5 Spectroscopy Organic Chemistry Degranulation tumor stroma General Medicine Mast cell medicine.disease Computer Science Applications Neoplasm Proteins Gene Expression Regulation Neoplastic Survival Rate 030104 developmental biology medicine.anatomical_structure lcsh:Biology (General) lcsh:QD1-999 Tumor progression 030220 oncology & carcinogenesis Cancer research MCF-7 Cells Female IL17A IFNγ |
Zdroj: | International Journal of Molecular Sciences Volume 21 Issue 15 International Journal of Molecular Sciences, Vol 21, Iss 5293, p 5293 (2020) |
ISSN: | 1422-0067 |
Popis: | Breast cancer (BrC) affects millions of women yearly. Mast cells (MCs) are common components of breast tumors with documented agonistic and antagonistic roles in tumor progression. Understanding the participation of MCs in BrC may lead to new therapies to control tumor growth. In this study, we looked into mechanistic models of MC responses triggered by BrC cells (BrCC), assessing both early degranulation and late transcriptional activities. We used aggressive and non-aggressive BrCC to model the progressive staging of the disease over HMC1 and LAD-2 human MC lines. We found that both MC lines were chemoattracted by all BrCC, but their activation was preferentially induced by aggressive lines, finding differences in their active transcriptional programs, both at basal level and after stimulation. Among those genes with altered expression were down-regulated SPP1, PDCD1, IL17A and TGFB1 and up-regulated KITLG and IFNG. A low expression of SPP1 and a high expression of KITLG and IFNG were associated with increased overall survival of BrC patients from public databases. The set of altered genes is more often associated with tumor stromas enriched with anti-tumoral signals, suggesting that MCs may participate in tumor control. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |